41
Participants
Start Date
November 7, 2023
Primary Completion Date
March 15, 2029
Study Completion Date
March 15, 2029
Ixazomib Citrate
Given PO
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
RECRUITING
Mount Sinai Hospital, New York
RECRUITING
Abramson Cancer Center at Pennsylvania Hospital, Philadelphia
RECRUITING
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RECRUITING
University of Miami Miller School of Medicine, Miami
RECRUITING
University of Illinois Cancer Center, Chicago
RECRUITING
Washington University, St Louis
RECRUITING
Thomas Street Clinic, Houston
RECRUITING
UC San Diego, San Diego
RECRUITING
Zuckerberg San Francisco General Hospital, San Francisco
RECRUITING
Virginia Mason Medical Center, Seattle
National Cancer Institute (NCI)
NIH
AIDS Malignancy Consortium
NETWORK